About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
To download the full report, click here.
The vast majority of the world’s medical innovation occurs in the United States because of a reliable patent system where risk is rewarded, innovators are protected, and a predictable flow of resources fuels continuous research and development. In 2015, America’s biopharmaceutical sector invested nearly $60 billion in R&D—double the automotive and aerospace industries combined—and supported 4.5 million American jobs. Trade agreements with other nations extend this mutually beneficial arrangement into new frontiers, helping us reach patients and consumers who would otherwise not have access to the latest treatment and cures.
In many cases, as with Australia and South Korea, the United States has well-written trade agreements—that too often are ignored. In other cases, as with Turkey and the Russian Federation, U.S. trade partners attempt to circumvent restrictions by creating illegal (and illogical) requirements designed to favor local competitors at the expense of U.S. innovators.
The U.S. Government must hold its trading partners to account. The health of the American economy—and millions of patients around the world—hangs in the balance.
Tackling Impediments to Trade image
Report
Trade
Tackling Impediments to Trade
Tackling Impediments to Trade image